Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

South Korea Spinal Cord Compression Spinal Stenosis Market

ID: MRFR/HC/55192-HCR
200 Pages
Satyendra Maurya
Last Updated: April 02, 2026

South Korea Spinal Cord Compression Spinal Stenosis Market Research Report By Type (Lumbar Spinal Stenosis, Cervical Stenosis, Central Stenosis), By Diagnosis (Physical Examination, Imaging), By Treatment Type (Surgical Treatment, Non-Surgical Treatment) and By End User (Hospitals, Ambulatory Surgical Centers, Rehabilitation Centers) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

South Korea Spinal Cord Compression Spinal Stenosis Market Infographic
Purchase Options
  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
    1. 1.1 EXECUTIVE SUMMARY | |
      1. 1.1.1 Market Overview | |
      2. 1.1.2 Key Findings | |
      3. 1.1.3 Market Segmentation | |
      4. 1.1.4 Competitive Landscape | |
      5. 1.1.5 Challenges and Opportunities | |
      6. 1.1.6 Future Outlook 2
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
    1. 2.1 MARKET INTRODUCTION | |
      1. 2.1.1 Definition | |
      2. 2.1.2 Scope of the study | | |
        1. 2.1.2.1 Research Objective | | |
        2. 2.1.2.2 Assumption | | |
        3. 2.1.2.3 Limitations |
    2. 2.2 RESEARCH METHODOLOGY | |
      1. 2.2.1 Overview | |
      2. 2.2.2 Data Mining | |
      3. 2.2.3 Secondary Research | |
      4. 2.2.4 Primary Research | | |
        1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
        2. 2.2.4.2 Breakdown of Primary Respondents | |
      5. 2.2.5 Forecasting Model | |
      6. 2.2.6 Market Size Estimation | | |
        1. 2.2.6.1 Bottom-Up Approach | | |
        2. 2.2.6.2 Top-Down Approach | |
      7. 2.2.7 Data Triangulation | |
      8. 2.2.8 Validation 3
  3. SECTION III: QUALITATIVE ANALYSIS |
    1. 3.1 MARKET DYNAMICS | |
      1. 3.1.1 Overview | |
      2. 3.1.2 Drivers | |
      3. 3.1.3 Restraints | |
      4. 3.1.4 Opportunities |
    2. 3.2 MARKET FACTOR ANALYSIS | |
      1. 3.2.1 Value chain Analysis | |
      2. 3.2.2 Porter's Five Forces Analysis | | |
        1. 3.2.2.1 Bargaining Power of Suppliers | | |
        2. 3.2.2.2 Bargaining Power of Buyers | | |
        3. 3.2.2.3 Threat of New Entrants | | |
        4. 3.2.2.4 Threat of Substitutes | | |
        5. 3.2.2.5 Intensity of Rivalry | |
      3. 3.2.3 COVID-19 Impact Analysis | | |
        1. 3.2.3.1 Market Impact Analysis | | |
        2. 3.2.3.2 Regional Impact | | |
        3. 3.2.3.3 Opportunity and Threat Analysis 4
  4. SECTION IV: QUANTITATIVE ANALYSIS |
    1. 4.1 Medical Device, BY Type (USD Million) | |
      1. 4.1.1 Cervical Stenosis | |
      2. 4.1.2 Central Stenosis | |
      3. 4.1.3 Lumbar Spinal Stenosis |
    2. 4.2 Medical Device, BY Diagnosis (USD Million) | |
      1. 4.2.1 Physical Examination | |
      2. 4.2.2 Imaging |
    3. 4.3 Medical Device, BY Treatment Type (USD Million) | |
      1. 4.3.1 Surgical Treatment | |
      2. 4.3.2 Non-Surgical Treatment |
    4. 4.4 Medical Device, BY End-Users (USD Million) | |
      1. 4.4.1 Ambulatory Surgical Centers | |
      2. 4.4.2 Rehabilitation Centers | |
      3. 4.4.3 Hospitals 5
  5. SECTION V: COMPETITIVE ANALYSIS |
    1. 5.1 Competitive Landscape | |
      1. 5.1.1 Overview | |
      2. 5.1.2 Competitive Analysis | |
      3. 5.1.3 Market share Analysis | |
      4. 5.1.4 Major Growth Strategy in the Medical Device | |
      5. 5.1.5 Competitive Benchmarking | |
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Medical Device | |
      7. 5.1.7 Key developments and growth strategies | | |
        1. 5.1.7.1 New Product Launch/Service Deployment | | |
        2. 5.1.7.2 Merger & Acquisitions | | |
        3. 5.1.7.3 Joint Ventures | |
      8. 5.1.8 Major Players Financial Matrix | | |
        1. 5.1.8.1 Sales and Operating Income | | |
        2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
    2. 5.2 Company Profiles | |
      1. 5.2.1 Medtronic (US) | | |
        1. 5.2.1.1 Financial Overview | | |
        2. 5.2.1.2 Products Offered | | |
        3. 5.2.1.3 Key Developments | | |
        4. 5.2.1.4 SWOT Analysis | | |
        5. 5.2.1.5 Key Strategies | |
      2. 5.2.2 DePuy Synthes (US) | | |
        1. 5.2.2.1 Financial Overview | | |
        2. 5.2.2.2 Products Offered | | |
        3. 5.2.2.3 Key Developments | | |
        4. 5.2.2.4 SWOT Analysis | | |
        5. 5.2.2.5 Key Strategies | |
      3. 5.2.3 Stryker (US) | | |
        1. 5.2.3.1 Financial Overview | | |
        2. 5.2.3.2 Products Offered | | |
        3. 5.2.3.3 Key Developments | | |
        4. 5.2.3.4 SWOT Analysis | | |
        5. 5.2.3.5 Key Strategies | |
      4. 5.2.4 NuVasive (US) | | |
        1. 5.2.4.1 Financial Overview | | |
        2. 5.2.4.2 Products Offered | | |
        3. 5.2.4.3 Key Developments | | |
        4. 5.2.4.4 SWOT Analysis | | |
        5. 5.2.4.5 Key Strategies | |
      5. 5.2.5 Zimmer Biomet (US) | | |
        1. 5.2.5.1 Financial Overview | | |
        2. 5.2.5.2 Products Offered | | |
        3. 5.2.5.3 Key Developments | | |
        4. 5.2.5.4 SWOT Analysis | | |
        5. 5.2.5.5 Key Strategies | |
      6. 5.2.6 Boston Scientific (US) | | |
        1. 5.2.6.1 Financial Overview | | |
        2. 5.2.6.2 Products Offered | | |
        3. 5.2.6.3 Key Developments | | |
        4. 5.2.6.4 SWOT Analysis | | |
        5. 5.2.6.5 Key Strategies | |
      7. 5.2.7 Globus Medical (US) | | |
        1. 5.2.7.1 Financial Overview | | |
        2. 5.2.7.2 Products Offered | | |
        3. 5.2.7.3 Key Developments | | |
        4. 5.2.7.4 SWOT Analysis | | |
        5. 5.2.7.5 Key Strategies | |
      8. 5.2.8 Aesculap (DE) | | |
        1. 5.2.8.1 Financial Overview | | |
        2. 5.2.8.2 Products Offered | | |
        3. 5.2.8.3 Key Developments | | |
        4. 5.2.8.4 SWOT Analysis | | |
        5. 5.2.8.5 Key Strategies |
    3. 5.3 Appendix | |
      1. 5.3.1 References | |
      2. 5.3.2 Related Reports 6 LIST OF FIGURES |
    4. 6.1 MARKET SYNOPSIS |
    5. 6.2 SOUTH KOREA MARKET ANALYSIS BY TYPE |
    6. 6.3 SOUTH KOREA MARKET ANALYSIS BY DIAGNOSIS |
    7. 6.4 SOUTH KOREA MARKET ANALYSIS BY TREATMENT TYPE |
    8. 6.5 SOUTH KOREA MARKET ANALYSIS BY END-USERS |
    9. 6.6 KEY BUYING CRITERIA OF MEDICAL DEVICE |
    10. 6.7 RESEARCH PROCESS OF MRFR |
    11. 6.8 DRO ANALYSIS OF MEDICAL DEVICE |
    12. 6.9 DRIVERS IMPACT ANALYSIS: MEDICAL DEVICE |
    13. 6.10 RESTRAINTS IMPACT ANALYSIS: MEDICAL DEVICE |
    14. 6.11 SUPPLY / VALUE CHAIN: MEDICAL DEVICE |
    15. 6.12 MEDICAL DEVICE, BY TYPE, 2024 (% SHARE) |
    16. 6.13 MEDICAL DEVICE, BY TYPE, 2024 TO 2035 (USD Million) |
    17. 6.14 MEDICAL DEVICE, BY DIAGNOSIS, 2024 (% SHARE) |
    18. 6.15 MEDICAL DEVICE, BY DIAGNOSIS, 2024 TO 2035 (USD Million) |
    19. 6.16 MEDICAL DEVICE, BY TREATMENT TYPE, 2024 (% SHARE) |
    20. 6.17 MEDICAL DEVICE, BY TREATMENT TYPE, 2024 TO 2035 (USD Million) |
    21. 6.18 MEDICAL DEVICE, BY END-USERS, 2024 (% SHARE) |
    22. 6.19 MEDICAL DEVICE, BY END-USERS, 2024 TO 2035 (USD Million) |
    23. 6.20 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
    24. 7.1 LIST OF ASSUMPTIONS | |
      1. 7.1.1 |
    25. 7.2 South Korea MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.2.1 BY TYPE, 2025-2035 (USD Million) | |
      2. 7.2.2 BY DIAGNOSIS, 2025-2035 (USD Million) | |
      3. 7.2.3 BY TREATMENT TYPE, 2025-2035 (USD Million) | |
      4. 7.2.4 BY END-USERS, 2025-2035 (USD Million) |
    26. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
      1. 7.3.1 |
    27. 7.4 ACQUISITION/PARTNERSHIP | |

South Korea Medical Device Market Segmentation

Medical Device By Type (USD Million, 2025-2035)

  • Cervical Stenosis
  • Central Stenosis
  • Lumbar Spinal Stenosis

Medical Device By Diagnosis (USD Million, 2025-2035)

  • Physical Examination
  • Imaging

Medical Device By Treatment Type (USD Million, 2025-2035)

  • Surgical Treatment
  • Non-Surgical Treatment

Medical Device By End-Users (USD Million, 2025-2035)

  • Ambulatory Surgical Centers
  • Rehabilitation Centers
  • Hospitals

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions